Clinical Trials Browser

Phase 2/3 × Has results × Sodium Chloride × Clear all

NCT02641639 2025-03-24

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Phase 2/3 Terminated

70 enrolled 16 charts

Platinum Resistant Ovarian Cancer

NCT01379183 2016-03-21

Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility

Phase 2/3 Completed

40 enrolled 10 charts

Multiple Endocrine Neoplasia Type 1